Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells

25 Aug 2020

Abstract excerpt

Chronic active Epstein-Barr virus (CAEBV) typically presents as persistent infectious mononucleosis-like disease and/or hemophagocytic lymphohistocytosis (HLH), reflecting ectopic Epstein-Barr virus (EBV) infection and lymphoproliferation of T and/or NK cells. Clinical behavior ranges from indolent, stable disease through to rapidly progressive, life-threatening disease. Although it is thought the chronicity...

Topics

Join the communities discussing this publication.

Autoimmune and Inflammatory Disorders Research
Immune Cell Function and Interaction
Viral-associated cancers and disorders

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33443553
DOI: 10.1182/blood.2020005611

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cellsPMID 33443553Read ↗

Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection.Semantic proximity Read ↗

Chronic active Epstein-Barr virus disease originates from infected hematopoietic stem cellsSemantic proximity Read ↗

Epstein–Barr virus-positive T/NK-cell lymphoproliferative disordersSemantic proximity Read ↗

Oncogenicity of EBV-infected natural killer T cells deteriorate EBV-related hemophagocytic lymphohistiocytosisSemantic proximity Read ↗

A high-resolution, unbiased analysis of the cellular immune response to Epstein-Barr virusSemantic proximity Read ↗

A high-resolution, unbiased analysis of the cellular immune response to Epstein-Barr virusSemantic proximity Read ↗

Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes.Semantic proximity Read ↗

Epstein‐Barr Virus–Associated Hemophagocytic Lymphohistiocytosis in Adults Characterized by High Viral Genome Load within Circulating Natural Killer CellsSemantic proximity Read ↗

Immune regulation in Epstein-Barr virus-associated diseasesSemantic proximity Read ↗

Detection of latent Epstein-Barr virus gene expression in single-cell sequencing of peripheral blood mononuclear cellsSemantic proximity Read ↗

Pathogenic roles for Epstein–Barr virus (EBV) gene products in EBV-associated proliferative disordersSemantic proximity Read ↗

Multiomics analysis reveals the genetic and epigenetic features of high-risk NK cell–type chronic active EBV infectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.